$1.570
-0.153 (-9.77%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACRV Prediction & Forecast by Similar Chart Analysis
Alphio's ACRV stock price prediction model matches the current Acrivon Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.57 (+0.24%). The 1-week path is $1.60 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acrivon Therapeutics, Inc. Stock?
Acrivon Therapeutics Inc is currently not a strong buy due to its low price and negative earnings, but it shows potential for recovery. The current price is $1.61, significantly below the 52-week high of $3.56, indicating a 14.8% position within its 52-week range. However, the RSI is at 27.156, suggesting the stock is oversold, which could indicate a potential rebound. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$19,042,000 in Q1 2026. The main risk is the ongoing negative earnings trend, as indicated by the EPS of -0.49 for Q1 2026, which may deter investors in the short term.
ACRV stock price ended at $1.57 on Thursday, after losing -9.77%
Acrivon Therapeutics, Inc. (ACRV) last closed at $1.5700001, losing -9.77%. These facts feed the 1-day and 1-week ACRV price prediction above.
Forecast Drivers
Acrivon Therapeutics, Inc. (ACRV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACRV, ranked by similarity.
Seasonality analysis for ACRV
Historically the probability of a positive November return for ACRV is 45.45%. December offers the highest probability of a positive month at 48.84%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACRV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.48 | $1.55 | $1.73 | -1.42% |
| Dec 2026 | $1.21 | $1.27 | $1.53 | -19.31% |
In 2026, Acrivon Therapeutics, Inc. (ACRV) is projected to range from $1.21 to $1.73.
Acrivon Therapeutics, Inc. 2026 monthly forecast
In Nov 2026, Acrivon Therapeutics, Inc. is projected to average $1.55, with a low of $1.48 and high of $1.73.
In Dec 2026, Acrivon Therapeutics, Inc. is projected to average $1.27, with a low of $1.21 and high of $1.53.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.